NDC 71610-815
Brilinta 90 mg tablet
On the label: Aphena Pharma Solutions - Tennessee, Inc.. It's repackaged: Aphena Pharma Solutions - Tennessee, Inc. rebottles it from AstraZeneca Pharmaceuticals LP's NDC 0186-0777.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants AstraZeneca Pharmaceuticals LP names for other drugs.
Repackaging site
- Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN, United States · repackages it
Recalls
- Mar 15, 2021 · Class II · Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots: MP0138 - May 25, 2017 · Class I · AstraZeneca Pharmaceuticals, LP
Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.
Lots: Lot # JB5047, Exp 10/19
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ticagrelor: every company that makes it
- Form
- tablet, oral
- Strength
- 90 mg
- Approval
- NDA NDA022433
- On the market since
- Aug 5, 2011
- Package NDCs
71610-815-41- Official label
- DailyMed (National Library of Medicine), updated Apr 8, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?